Free Trial
Final Hours! MarketBeat All Access at $149 Until 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$149.65
-2.6%
$150.64
$130.23
▼
$200.43
$10.72B1.671.06 million shs199,265 shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$42.77
+0.2%
$44.93
$39.57
▼
$105.65
$61.65B0.5818.67 million shs4.31 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$101.20
-0.2%
$95.41
$72.76
▼
$107.62
$8.37B0.24934,380 shs58,181 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$87.15
-6.7%
$88.68
$59.74
▼
$94.85
$5.20B0.51786,044 shs406,973 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.06%-1.16%+6.74%-9.13%+16.53%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+1.41%-7.25%-2.42%-8.68%-57.40%
HealthEquity, Inc. stock logo
HQY
HealthEquity
+0.02%+0.39%+16.17%+0.75%+7.33%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+1.28%-0.59%+6.28%+9.86%+14.74%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$149.65
-2.6%
$150.64
$130.23
▼
$200.43
$10.72B1.671.06 million shs199,265 shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$42.77
+0.2%
$44.93
$39.57
▼
$105.65
$61.65B0.5818.67 million shs4.31 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$101.20
-0.2%
$95.41
$72.76
▼
$107.62
$8.37B0.24934,380 shs58,181 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$87.15
-6.7%
$88.68
$59.74
▼
$94.85
$5.20B0.51786,044 shs406,973 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.06%-1.16%+6.74%-9.13%+16.53%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+1.41%-7.25%-2.42%-8.68%-57.40%
HealthEquity, Inc. stock logo
HQY
HealthEquity
+0.02%+0.39%+16.17%+0.75%+7.33%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+1.28%-0.59%+6.28%+9.86%+14.74%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.53
Moderate Buy$190.0023.61% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.68
Moderate Buy$61.8744.93% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
2.92
Moderate Buy$113.5312.01% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.62
Moderate Buy$100.457.56% Upside

Current Analyst Ratings Breakdown

Latest BSX, ALGN, HQY, and MMSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/30/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Reiterated RatingBuy$106.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price Target$52.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price Target$48.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$70.00 ➝ $52.00
10/29/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
Lower Price TargetEqual Weight$188.00 ➝ $175.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetNeutral$48.00 ➝ $44.00
10/29/2026
Align Technology, Inc. stock logo
ALGN
Align Technology
Reiterated RatingHold
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$55.00 ➝ $50.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price Target$50.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$66.00 ➝ $48.00
10/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetOutperform$54.00 ➝ $49.00
(Data available from 10/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.03B2.73$11.88 per share12.94$56.43 per share2.72
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$21.07B2.94$4.06 per share10.52$16.49 per share2.59
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.31B6.38$5.28 per share19.21$24.66 per share4.11
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.52B3.68$5.95 per share15.69$26.72 per share3.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$410.35M$5.7516.4714.891.6511.83%16.11%10.56%N/A
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.3618.0912.701.0416.62%18.73%10.65%N/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
$215.20M$2.7736.5921.941.6017.36%15.33%9.51%12/2/2026 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.4225.1222.402.309.22%13.75%8.10%N/A

Latest BSX, ALGN, HQY, and MMSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.04$1.12+$0.08$0.70$410.56 million$416.24 million
10/28/2026Q3 2026
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.77$2.80+$0.03$1.90$1.00 billion$1.01 billion
10/28/2026Q3 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.7270$0.73+$0.0030$0.40$5.09 billion$5.14 billion
8/27/2026Q2 2027
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.19$1.24+$0.05$0.78$349.22 million$350.73 million
7/30/2026Q2 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.9590$1.19+$0.2310$0.65$405.25 million$418.84 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.40
1.28
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.47
2.99
2.99
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.44
4.20
2.79

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.75%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.60%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,29071.62 million71.08 millionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
2,81482.71 million81.39 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.71 million59.29 millionOptionable

Recent News About These Companies

Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
Merit Medical Systems Q3 Earnings Call Highlights
Merit Medical Systems Inc Reveals Increase In Q3 Profit
Merit Medical Systems Q3 2026 Earnings Call Transcript
Merit Medical Raises Outlook After Strong Third Quarter
Accelerating Organic Growth Propels Merit Medical Systems (MMSI)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Align Technology stock logo

Align Technology NASDAQ:ALGN

$149.65 -4.06 (-2.64%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$42.77 +0.08 (+0.18%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$101.20 -0.17 (-0.16%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$87.15 -6.24 (-6.68%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.